Back

The effect of eplerenone vs irbesartan as first line therapy in obese hypertensive patients on left ventricular hypertrophy and diastolic dysfunction: echocardiographic results of the HEBRO randomized

31 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Hypertension treatment (2) Target Organ Damage/Left Ventricular Hypertrophy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Maria Kouremeti

Hippokration General Hospital, Athens (Greece)

5 More presentations in this session

Presentation thumbnail
Six-month renal marker trajectories with azilsartan–indapamide versus azilsartan–nitrendipine in essential hypertension: a pragmatic comparative study
Assistant Professor Z. Mashkurova (Tashkent, UZ)
Abstract
Presentation thumbnail
Sex specific associations between blood pressure in midlife and left ventricular hypertrophy in older women and men
Doctor E. Kringeland (Bergen, NO)
Abstract
Presentation thumbnail
Effects of colchicine on cardiac structure and function in patients with hypertension: a prespecified secondary analysis of the COlchicine HypERtENsion Trial (COHERENT)
Doctor A. Langhoff (Copenhagen, DK)
Abstract
Presentation thumbnail
Perception of self-efficacy improves adherence in hypertensive patients
Associate Professor A. Farcas (Cluj Napoca, RO)
Abstract
Presentation thumbnail
Gender, age and regional disparities in antihypertensive prescribing and medication adherence: evidence from linked survey and claims data
Professor S. Spethmann (Berlin, DE)
Abstract

Access the full session

Session thumbnail
Hypertension treatment (2)

The Event

Event poster

ESC Congress 2026

31 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Sequential nephron blockade with diuretics improves diastolic dysfunction in patients with resistant hypertension, a substudy a the PHARES trial
1 September 2019
thumbnail
Congress Presentation
Time to change the electrocardiography (ECG) indices of left ventricular hypertrophy: the Bialystok PLUS and SHIP-TREND population-based studies
5 April 2025
thumbnail
Congress Presentation
Role of aldosterone in long-term left ventricular remodelling after acute myocardial infarction: the REMI study
22 May 2023
thumbnail
Congress Presentation
Eplerenone versus spironolactone and outcomes in patients with heart failure: a nationwide cohort study
21 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources